Jeff Nelson

Experience

Jeff Nelson was appointed Chief Executive Officer of Regenity Biosciences in October 2026 and has been serving as Executive Chairman of the Board of Directors since Linden’s acquisition of the company in 2019. A veteran healthcare executive with more than 35 years in the services and medical device sectors, he previously served as CEO of Healogics and President of the cardiovascular division of Thoratec Corporation, and held senior leadership roles at Philips Medical Systems. Jeff also served as Executive Chairman of Linden portfolio company Pinnacle Treatment Centers, and sat on the Board of Governors of the Packard Center for ALS Research at Johns Hopkins University. He previously served on the Boards of Directors of Dimensional Dental Management and CarePoint Partners Holdings.

Leadership Team

Read More

Phil Stead

Chief Revenue Officer

Read More

Jim Pomeroy

Vice President, Quality and Regulatory Affairs

Read More

Aaron Kendrick

Senior Vice President Operations

Read More

Susan Miller

Head of Human Resources

Read More

Jessica Swanson

Vice President of Marketing

Read More

Bill Messer

Vice President of Commercial Operations

Read More

Peggy Hansen

General Manager, Contract Development + Manufacturing & Senior Vice President, Regulatory, Quality and Clinical Affairs

Read More

Oystein Valberg

Chief Financial Officer

Careers

Looking for a career with purpose? Join our team and work with us to develop life-changing products that help patients heal. Visit our careers page to learn more about what sets Regenity apart.

Careers